Publication Beamlines Strategic Pillar
Boechler, Anna-Maria; Pelly, Dallas; Walker, Tracy; Blyth, Robert I.R.; Muir, David et al. (2025). STEM education activities at the Canadian Light Source. Canadian Journal of Chemistry 103(10) , 668-674. 10.1139/cjc-2024-0243.
Fraund, Matthew; Park, Tim; Yao, Lin; Bonanno, Daniel; Pham, Don Q. et al. (2018). Quantitative capabilities of STXM to measure spatially resolved organic volume fractions of mixed organic/inorganic particle. Atmospheric Measurement Techniques Discussions , 1-27. 10.5194/amt-2018-351.
Wurtz, W.A. (2018). Coupling control and optimization at the Canadian Light Source. Nuclear Instruments and Methods in Physics Research. Section A: Accelerators. Spectrometers. Detectors and Associated Equipment 892, 1-9. 10.1016/j.nima.2018.02.082.
(2024). Exit Window for Electron Beam in Isotope Production. Patent Number: IL268283B2.
(2019). Prolactin receptor binding proteins and uses thereof. Patent Number: IL239502B.
(2018). . Patent Number: NO2968312T3.
(2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: IL279484A.
(2018). Antibody polypeptides that antagonize cd40. Patent Number: IL228720B.
(2023). CORE/CASING ENGINEERING WITH GAPS (CSVE) OF CATALYST FOR ELECTROCHEMICAL CO2 REDUCTION. Patent Number: PT3791010T.
(2018). Methods and compositions. Patent Number: GB201817444D0.
(2018). . Patent Number: NO2699601T3.
(2020). Combination of lif inhibitors and pd-1 axis inhibitors for use in treating cancer. Patent Number: IL277918A.
(2018). Antibody epitope. Patent Number: IL256097A.
(2021). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: IL279444A.
(2021). ANTIBODY. Patent Number: PT3311170T.